← SynDRA
XYLAZINE
SynDRA canonical compound SYN0002226 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRA2A | ADRA2B | ADRA2C |
| Mechanism of action | adrenergic receptor agonist |
| Indication | anesthetic |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- ADRA2A AGONIST
- ADRA2A PARTIAL AGONIST
- ADRA2B AGONIST
- ADRA2C AGONIST
- adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APEX1
- ARSA
- TDP1
- SLCO1B3
- SLCO1B1
- SAMHD1
- RAB9A
- PMP22
- MAPT
- LMNA
- HDAC6
- EHMT2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- BLM
- BAZ2B
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Analgesics
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
- Muscle Relaxants, Central
- Neuromuscular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
Cross-references
Synonyms
- AnaSed
- Rompun
- chanazine
- NSC-758142
- xylazine hydrochloride
- Xilazina
- Chanazine
- Xylazine component of tranq
- Bayer 1470
- Narcoxyl
- Xylapan
- Xylasol
- Xylzin
- BAY-VA-1470
- Xylazin
- Xylazinum
- BAY 1470
- WH 7286
- Rometar
- Xylazine (free base)
- MFCD00057908
- NSC 758142
- 2KFG9TP5V8
- MLS000054617
- CHEMBL297362
- NCGC00016098-07
- SMR000061135
- CAS-7361-61-7
- Primazine
- Sedomin
- Xylazinum [INN-Latin]
- Xilazina [INN-Spanish]
- UNII-2KFG9TP5V8
- SR-01000075296
- EINECS 230-902-1
- Xylazine [USP:INN:BAN]
- xilazine
- Xylazine-d6
Look up XYLAZINE in the interactive SynDRA portal →